Results reinforce that Amplatzer Piccolo™ Occluder is safe and effective for closing an opening in the heart known as a "patent ductus arteriosus" (PDA) in newborns Study found low adverse event ...

Born at 17 weeks early with holes in their hearts, these premature twins in New Orleans were some of the first to receive noninvasive heart surgery. "It's very vulnerable," mother Ashley Lane said.

Suddenly, the procedure with the Piccolo Occluder turned out to be Irie’s only option for survival. “She wasn’t getting better so we had to take a leap of faith that this device would work ...

SAN FRANCISCO, Sept. 16, 2024 /PRNewswire/ -- Piccolo Medical, Inc. (Piccolo) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its ...

Results reinforce that Amplatzer Piccolo™ Occluder is safe and effective for closing an opening in the heart known as a "patent ductus arteriosus" (PDA) in newborns Study found low adverse event rates ...

ABBOTT PARK, Ill., Sept. 8, 2022 /PRNewswire/ -- Abbott (NYSE: ABT) today announced three-year data showing the positive impact of the Amplatzer Piccolo™ Occluder on treating babies (some ...